At the Top
Dr. Dixon Kaufman was notified by the NIH NIAID that his U01 submission titled “Tomotherapy and Hematopoietic Cells for Tolerance to Kidney Transplants” was awarded and funding will be initiated by July 1. The total amount awarded is $4.1M over five years. Collaborators include Dr. Will Burlingham, Dr. Peiman Hematti, and Dr. Luis Fernandez at the SMPH and Dr. Sam Strober at Stanford University. This project will be administered from the Nonhuman Primate Transplantation Tolerance Cooperative Study Group (NHPCSG). The NIH has asked that the University of Wisconsin consider administering the Opportunities Pool Fund of the NHPCSG. The Opportunities Pool Fund is awarded as a separate administrative supplement (approximately $1M annually) to the parent grant. Further conversations will occur this week with the NIH, Dr. Kaufman, Department, and SMPH representatives. We will keep you posted on this AMAZING accomplishment.
Dr. Vanessa Nomellini, General Surgery PGY-2 (soon to be 3) was appointed to the AAMC Organization of Resident Representatives (ORR) for the 2012-2013 ORR appointment cycle. Dr. Kent, in his role on the executive council for the Society of Surgical Chairs, submitted Dr. Nomellini’s name and she was chosen based on her outstanding CV and background.
Clinical News and Innovation
Dr. Takushi Kohmoto notified us that Dr. Jon Matsumura assisted Dr. Amish Raval, Assistant Professor of Medicine, and the TAVI team with the first percutaneous access done on a TAVI patient – all others prior to this at UW had been surgical cut downs. This is a terrific milestone/success achieved last week. The patient was discharged to home within 48 hours of the procedure and reported feeling great. Patients with cut downs are leaving in 72 hours. The mean length of stay in the Pivotal Partner B trial (inoperable AS vs. medical therapy) was about 10 days. Congratulations to a remarkable team.
Dr. Lee Wilke presented at a Sisters Network Inc. Fight Fear Cancer Summit in Milwaukee on Saturday, June 16. The organization is dedicated to increasing local and national attention to the devastating impact that breast cancer has in the African American community.
Prof. Adam L. Penenberg, of the Arthur L. Carter Journalism Institute at New York University, met with Dr. Carla Pugh, Director of the Clinical Simulation Program, and Sue Olson, senior simulation educator, and toured the simulation center and Dr. Pugh’s lab. He is writing a book on the uses of simulators for surgical education. He is also a contributing writer to Fast Company magazine, and writes for the New York Times, Slate, the Economist, and others.